PRGO Straddle Strategy
PRGO (Perrigo Company plc), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NYSE.
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands.
PRGO (Perrigo Company plc) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $1.38B, a beta of 0.52 versus the broader market, a 52-week range of 9.23-28.44, average daily share volume of 3.2M, a public-listing history dating back to 1991, approximately 8K full-time employees. These structural characteristics shape how PRGO stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.52 indicates PRGO has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. PRGO pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a straddle on PRGO?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current PRGO snapshot
As of June 26, 2026, spot at $9.90, ATM IV 99.60%, IV rank 27.71%, expected move 28.55%. The straddle on PRGO below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 21-day expiry.
Why this straddle structure on PRGO specifically: PRGO IV at 99.60% is on the cheap side of its 1-year range, which favors premium-buying structures like a PRGO straddle, with a market-implied 1-standard-deviation move of approximately 28.55% (roughly $2.83 on the underlying). The 21-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PRGO expiries trade a higher absolute premium for lower per-day decay. Position sizing on PRGO should anchor to the underlying notional of $9.90 per share and to the trader's directional view on PRGO stock.
PRGO straddle setup
The PRGO straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PRGO near $9.90, the first option leg uses a $9.90 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PRGO chain at a 21-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PRGO shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $9.90 | N/A |
| Buy 1 | Put | $9.90 | N/A |
PRGO straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
PRGO straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on PRGO. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on PRGO
Straddles on PRGO are pure-volatility plays that profit from large moves in either direction; traders typically buy PRGO straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
PRGO thesis for this straddle
The market-implied 1-standard-deviation range for PRGO extends from approximately $7.07 on the downside to $12.73 on the upside. A PRGO long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current PRGO IV rank near 27.71% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on PRGO at 99.60%. As a Healthcare name, PRGO options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PRGO-specific events.
PRGO straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PRGO positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PRGO alongside the broader basket even when PRGO-specific fundamentals are unchanged. Always rebuild the position from current PRGO chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on PRGO?
- A straddle on PRGO is the straddle strategy applied to PRGO (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With PRGO stock trading near $9.90, the strikes shown on this page are snapped to the nearest listed PRGO chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are PRGO straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the PRGO straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 99.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a PRGO straddle?
- The breakeven for the PRGO straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PRGO market-implied 1-standard-deviation expected move is approximately 28.55%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on PRGO?
- Straddles on PRGO are pure-volatility plays that profit from large moves in either direction; traders typically buy PRGO straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current PRGO implied volatility affect this straddle?
- PRGO ATM IV is at 99.60% with IV rank near 27.71%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.